SEC 13F Intelligence

Managers / Q1 2023 · view latest →

Avenir Management Company, LLC

CIK 0001866419 · 817 BROADWAY, 12TH FLOOR, NEW YORK, NY, 10003 · 516-318-6545

Reported Value
$20M
Q1 2023
Positions
4
Filings on Record
8
2019–present window
Filed
May 15, 2023
original filing

Summary

Avenir Management Company, LLC reported $20M in U.S.-listed holdings across 4 positions for Q1 2023.

The portfolio is heavily concentrated: LTCH alone accounts for 80.7% of reported value.

Compared with Q4 2022, the fund opened 0 new positions and exited 2.

Portfolio Metrics

Turnover
+6.7%
vs prior filed quarter
Largest Position
+80.7%
Latch

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $187MQ4 ’21Q1 ’22: $109MQ1 ’22Q2 ’22: $58MQ2 ’22Q3 ’22: $59MQ3 ’22Q4 ’22: $43MQ4 ’22Q1 ’23: $20MQ1 ’23Q2 ’23: $37MQ2 ’23Q3 ’23: $44MQ3 ’23filingsflow.com

Portfolio Composition

By security type
Common Stock: 96.8%Other: 3.2%
  • Common Stock · 96.8% · $20M
  • Other · 3.2% · $653,703

Quarter-over-Quarter Changes full breakdown →

vs Q4 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SNOWSNOWFLAKE INCSOLD OUT81.0K0$12M$0
GLOBAL E ONLINE LTDSOLD OUT484.3K0$10M$0
UBERUBER TECHNOLOGIES INCTRIMMED142.7K40.6K$3M$1M
LTCHLATCH INCHELD+021.44M+$1M$16M
CVNACARVANA COHELD+0201.2K+$1M$2M
FINCH THERAPEUTICS GROUP INCHELD+01.66M$144,713$653,703

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2023

4 positions
#IssuerClass% PortfolioValueShares
1LTCHLATCH INChistory →COM80.68%$16M21.44M
2CVNACARVANA COhistory →CL A9.73%$2M201.2K
3UBERUBER TECHNOLOGIES INChistory →COM6.36%$1M40.6K
4FINCH THERAPEUTICS GROUP INCCOM3.23%$653,7031.66M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2023$44M4Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$37M4Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$20M4May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$43M6Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$59M6Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$58M6Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$109M4May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$187M3Feb 14, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.